Labcorp
Labcorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
Labcorp COVID-19 Antibody Testing Available Nationwide Learn more >>>
Include date of birth, Social Security number (or other identification number), previous malignancy, drug therapy, radiation therapy, last menstrual period (LMP), postmenopausal patient (PMP), surgery (including surgical biopsies), exogenous hormones, abnormal vaginal bleeding, abnormal Pap results, IUD, and all other pertinent clinical information on the cytology test request form.
Note: In accordance with criteria established by CLIA, Pap tests will be referred for pathologist review if laboratory personnel suspect:
• Reactive or reparative cellular changes
• Atypical squamous or glandular cells of undetermined significance
• Cells in the premalignant or malignant category
In these cases, Labcorp will charge for the associated service. (Slides that are routinely reviewed by a pathologist for quality control purposes are not included.)
3 - 6 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Cervical cells in ThinPrep® vial
ThinPrep® vial
A minimum volume cannot be determined for the ThinPrep® vial, because it varies depending on the cellularity of the specimen.
ThinPrep® vial
ThinPrep® Vial − Broom or Brush/Spatula:
Broom-like collection technique: Obtain a sample from the cervix using a broom-like device by inserting the brush portion into the cervical os and then rotate the brush five times. Rinse the collection device in the PreservCyt® solution by pushing the brush into the bottom of the vial 10 times, forcing the bristles to bend apart to release the cervical material. As a final step, twirl the brush between the thumb and forefinger vigorously to release additional cellular material. Discard the collection device. Tighten the cap on the ThinPrep® vial so that the torque line on the cap passes the torque line on the vial.
Brush/spatula technique: Insert the brush into the endocervical canal until only the bottommost fibers are exposed. Slowly rotate the brush ¼ to ½ turn in one direction. Do not over-rotate the brush. Then, rotate the brush in the PreservCyt® solution 10 times while pushing against the wall of the ThinPrep® vial. Swirl the brush vigorously to release additional material. Discard the brush. Obtain an adequate sample from the ectocervix using a plastic spatula. Swirl vigorously in the ThinPrep® vial 10 times and discard the spatula. Tighten the cap on the ThinPrep® container so that the torque line on the cap passes the torque line on the vial.
Maintain specimen at room temperature. Specimens must be processed for testing within 21 days of collection for Pap.
Patient should avoid douches 48 to 72 hours prior to examination. Specimen should not be collected during or shortly after menstrual period.
Improper collection; inadequate specimen; improper labeling; specimen leaked in transit; quantity not sufficient for analysis; name discrepancies; specimen submitted on male patient; specimen submitted in vial that expired according to manufacturer's label; frozen specimen; SurePath™ vial. For Pap: liquid-based cytology specimen more than 21 days old. For HPV: specimen more than three months old in ThinPrep® vial.
Diagnose primary or metastatic neoplasm. This test aids in the diagnosis of sexually transmitted HPV infection and in the triage of patients with an abnormal Pap test result. High-risk HPV test is used for types 16,18,31,33,35,39,45, 51,52,56,58,59,66, and 68, without differentiation of the individual type. Positive high risk HPV test results reflex the sample for genotyping of types 16 and 18/45.
Failure to obtain adequate ectocervical, endocervical, or vaginal cell population is suboptimal for evaluation. Excessive use of lubricating jelly on the vaginal speculum will interfere with cytologic examination and may lead to unsatisfactory Pap results.
The use of the liquid-based cytology specimen for multiple tests may limit the volume available for Pap reprocessing or HPV testing. A negative result does not exclude the possibility of an HPV infection since very low levels of infection or sampling error may produce a false-negative result. This test detects only the 14 most common high-risk HPV types and cannot determine the specific HPV type present.
Image-guided liquid-based Pap test; nucleic acid amplification (NAA)
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
199350 | IGP,rfxAptima HPV all,16/18,45 | 191121 | Test ordered: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191108 | DIAGNOSIS: | 47528-5 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191166 | Interpretation | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191170 | Category: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191173 | Recommendation: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191169 | Infection: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191172 | Adequacy: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191111 | Recommendation: | 19773-1 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191109 | Specimen adequacy: | 19764-0 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191154 | Source: | 19763-2 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191160 | Clinician provided ICD9: | 52797-8 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191174 | Clinician provided ICD10: | 52797-8 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191107 | Clinical history: | 22636-5 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191124 | Amended report: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191110 | Additional comment: | 22638-1 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191125 | Addendum: | 22639-9 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191123 | Maturation index: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191112 | Performed by: | 19767-3 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191128 | QC reviewed by: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191145 | Diagnosis provided by: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191113 | Electronically signed by: | 19769-9 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191139 | Special procedure: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191129 | Cytology history: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191179 | Previous history: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191144 | QA comment: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 019018 | . | 11546-9 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191157 | Pathologist provided ICD9: | 52797-8 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191175 | Pathologist provided ICD10: | 52797-8 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 190120 | . | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 190109 | Note: | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 000000 | Test Methodology: | 47527-7 | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 190119 | . | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 019054 | N/A | |||
199350 | IGP,rfxAptima HPV all,16/18,45 | 191167 | Photomicrograph | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 019030 | . | N/A | ||
199350 | IGP,rfxAptima HPV all,16/18,45 | 019031 | Patient Counseling Report | N/A |
Reflex Table for Test Methodology: | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 192555 | Change IG Pap to LB Pap | 000000 | LBP CPT Code Automation | 47527-7 |
Reflex Table for . | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 507301 | HPV, high-risk | 507303 | HPV, high-risk | 30167-1 | |
Reflex 2 | 507405 | HPV, low volume rfx | 507405 | HPV, low volume rfx | 59420-0 |
Reflex Table for . | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 507805 | HPV, Aptima High 16/18,45 | 507801 | HPV Aptima | 59420-0 | |
Reflex 2 | 507825 | HPV Genotypes 16/18,45 | 507811 | HPV Genotype 16 | 59263-4 |
Reflex Table for . | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 507805 | HPV, Aptima High 16/18,45 | 507801 | HPV Aptima | 59420-0 | |
Reflex 2 | 507825 | HPV Genotypes 16/18,45 | 507812 | HPV Genotype 18,45 | 75694-0 |
Reflex Table for . | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 507805 | HPV, Aptima High 16/18,45 | 507801 | HPV Aptima | 59420-0 | |
Reflex 2 | 507825 | HPV Genotypes 16/18,45 | 507813 | HPV Genotype 16/18,45 Tracking | N/A |
Reflex Table for . | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 507805 | HPV, Aptima High 16/18,45 | 507801 | HPV Aptima | 59420-0 | |
Reflex 2 | 507825 | HPV Genotypes 16/18,45 | 019054 | N/A |
Reflex Table for . | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 507805 | HPV, Aptima High 16/18,45 | 019054 | N/A |
© 2020 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf